Harrison.ai
Executive Summary
Harrison.ai is a medical technology company from Sydney that builds artificial intelligence to help doctors read medical images more accurately. They use a special business model where they partner with industry leaders to form joint companies. Their main products come from partnerships named Annalise.ai and Franklin.ai. These tools help medical staff identify dozens of different health issues within CT scans and chest X-rays. The business is supported by top-tier investment firms such as Blackbird and Horizons. It is currently valued at more than $1 billion and makes around $60 million in sales each year. To stay ahead of other companies like Aidoc, the firm spends a lot of money on scientific research. This high spending results in a yearly loss of $25 million. Harrison.ai has a big advantage because it has exclusive access to medical data from the I-MED Radiology Network. They also have to convince doctors to actually use the new tech. A future public listing on the stock market would let regular people invest in this growing field and show if high-tech medical software can actually make money long-term.
Risk Analysis
Detailed risk factors, AI-graded risk score, financials, and analyst commentary for Harrison.ai are available to Pro subscribers.